Home Economy Europe hesitates on vaccine patent easing

Europe hesitates on vaccine patent easing

4

This article is an on-site version of our Coronavirus Business Update newsletter. Please share this with friends and colleagues who might find it valuable and let them know that, even if they are not subscribers to the Financial Times, they can read the newsletter — and all of the FT — free for 30 days. Welcome and please sign up here.

Covid cases and vaccinations

Total global cases: 156.0m

Total doses given: 1.2bn

Get the latest worldwide picture with our vaccine tracker

Latest news

For up-to-the-minute coronavirus updates, visit our live blog

Some experts question the utility of waiving patents

The US administration’s decision to back a patent waiver for Covid-19 vaccines has met with hesitation in Europe, particularly in countries with large pharmaceutical sectors, such as Switzerland.

Angela Merkel, the German chancellor, warned it would have “serious implications” for vaccine production worldwide and said the limiting…

Click here for full article…